HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cell senescence-associated porphyrin metabolism affects the efficacy of aminolevulinic acid-photodynamic diagnosis in bladder cancer.

Abstract
Aminolevulinic acid-photodynamic diagnosis (ALA-PDD) is a promising alternative method to detect cancer cells because of its high specificity and low rate of side effects. Exogenous ALA is administered and accumulates as protoporphyrin IX (PpIX) in cancer cells, which then emit red fluorescence following light irradiation to enable surgeons to accurately identify and remove cancerous tissue. Recent reports suggested that PpIX failed to accumulate in some patients who underwent ALA-PDD. We hypothesized that cell senescence, which is a relatively inactive state, affects porphyrin accumulation in bladder cancer cells. In this study, we evaluated the relationship between cell senescence and porphyrin accumulation in affecting the efficacy of ALA-PDD. First, we utilized three bladder cancer cell lines to evaluate senescence-related indicators and establish a cell senescence model. Then, we identified the differences in porphyrin production and the proteins involved in porphyrin accumulation between old and young cells. We found that compared with young cells, old cells possessed higher concentration of PpIX and had lower ABCG2 expression. The increase in PpIX levels following ABCG2 inhibition is three times higher in old cells than in young cells, suggesting that cell senescence was closely related with porphyrin accumulation in cancer. In conclusion, we found that the efficacy of ALA-PDD and porphyrin accumulation was relatively high in senescent cancer cells and that inhibition of ABCG2 could improve the efficacy of ALA-PDD in young bladder cancer cells.
AuthorsHung Wei Lai, Shinkuro Yamamoto, Hideo Fukuhara, Shun-Ichiro Ogura, Keiji Inoue
JournalPhotodiagnosis and photodynamic therapy (Photodiagnosis Photodyn Ther) Vol. 42 Pg. 103581 (Jun 2023) ISSN: 1873-1597 [Electronic] Netherlands
PMID37116819 (Publication Type: Journal Article)
CopyrightCopyright © 2023. Published by Elsevier B.V.
Chemical References
  • Aminolevulinic Acid
  • Photosensitizing Agents
  • Porphyrins
  • Protoporphyrins
Topics
  • Humans
  • Aminolevulinic Acid (pharmacology)
  • Photosensitizing Agents (pharmacology)
  • Photochemotherapy (methods)
  • Cell Line, Tumor
  • Porphyrins (pharmacology)
  • Protoporphyrins (metabolism)
  • Urinary Bladder Neoplasms (drug therapy, metabolism)
  • Cellular Senescence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: